782-I Phase I dose escalation of SAR445710, a PDL1-IL15 targeted cytokine in metastatic and/or advanced solid tumors

• Jason Luke,
• Ahmad A Tarhini,
• Anthony J Olszanski,
• Chen Zhu,
• Giovanni Abbadessa,
• Christos Fountzilas,
• Lee Rosen,
• Adyb Baakili,
• Timothy Wagenaar,
• Helene Guillemin-Paveau,
• Meijing Wu,
• Raymond Perez

Affiliations

Jason Luke

1UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Ahmad A Tarhini

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA

Anthony J Olszanski

2Fox Chase Cancer Center, Philadelphia, PA, USA

Chen Zhu

6Sanofi, Cambridge, MA, USA

Giovanni Abbadessa

6Sanofi, Cambridge, MA, USA

Christos Fountzilas

9Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Lee Rosen

3UCLA Division of Hematology-Oncology, Los Angeles, CA, USA

Adyb Baakili

5Sanofi-Aventis, Vitry-sur-Seine, France

Timothy Wagenaar

6Sanofi, Cambridge, MA, USA

Helene Guillemin-Paveau

7Sanofi, Paris, Chilly-Mazarin, France

Meijing Wu

6Sanofi, Cambridge, MA, USA

Raymond Perez

8Sanofi, Pennington, NJ, USA